Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Invested Capital: 2021

Historic Invested Capital for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $64.8 million.

  • Cardiol Therapeutics' Invested Capital rose 59.95% to $114.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $114.1 million, marking a year-over-year increase of 59.95%. This contributed to the annual value of $64.8 million for FY2021, which is N/A change from last year.
  • As of FY2021, Cardiol Therapeutics' Invested Capital stood at $64.8 million.
  • Over the past 5 years, Cardiol Therapeutics' Invested Capital peaked at $64.8 million during FY2021, and registered a low of $64.8 million during FY2021.
  • Over the past 1 years, Cardiol Therapeutics' median Invested Capital value was $64.8 million (recorded in 2021), while the average stood at $64.8 million.